Univdatos Whatsapp
Blood Transfusion Diagnostics Market

The Blood Transfusion Diagnostics Market is expected to foresee significant growth. APAC to lead the growth!

The blood transfusion diagnostics market is expected to register a CAGR of around ~7% over the period of 2021-2027. Blood transfusion diagnostics are the devices that are used to conduct tests before the transfusion of blood from donor to patient such as blood grouping disease screening. The main types of blood transfusion diagnostics are instruments and kits, reagents, and others. The blood transfusion diagnostic kits are used to collect and transfuse blood. There are some technologies of blood transfusion such as western blot, ELISA, nucleic acid amplification, fluorescence assay, and rapid test that are used for various applications such as blood grouping and disease screening. Furthermore, patients undergoing the surgical process need a blood transfusion to recover the blood lost in the body during the surgical process. Blood transfusion diagnostics are used during the process to monitor and diagnose the blood before transferring it to the patient’s body otherwise it will cause infectious diseases. According to the National Institutes of Health (NIH), approx 310 million surgeries are being performed each year in the U.S.

The COVID-19 outbreak will impact the blood transfusion diagnostics market in the initial phase of the forecast period. Due to nationwide lockdowns, the blood transfusion diagnostics market registered a certain decline during the pandemic majorly due to the denied blood transfusion diagnostics services and canceled or postponed elective surgeries by medical care providers due to the high risk of COVID-19. However, during the latter half of the pandemic, the demand for blood transfusion diagnostics products is expected to rise drastically worldwide.

 For a detailed analysis of the Blood transfusion diagnostics Market browse through https://univdatos.com/report/blood-transfusion-diagnostics-market/

Based on product type, the blood transfusion diagnostics market is segmented into reagents & kits and instruments. In 2020, The reagents and kits category is anticipated to witness a considerable growth rate over the forecast period owing to the increasing need for donor screening to prevent patients from unsuitable blood and blood products and combat TTIs. Furthermore, the rising prevalence of chronic and infectious diseases such as severe anemia, cancer, hemophilia, kidney disease, liver disease, severe infection, sickle cell disease, and thrombocytopenia and the introduction of technologically advanced products are among the factors driving the demand for reagents & kits.

Based on application, the blood transfusion diagnostics market has been segmented into blood grouping, and disease screening. In 2020, the Disease Screening category held the largest share and is anticipated to witness a considerable growth rate over the forecast period. Rising incidence of TTI worldwide, increasing safety screening of donated blood, safe transfusion, are some of the key factors driving the market. In addition, numerous countries, including the UAE, South Africa, and the U.S., have made TTI testing a mandatory protocol.

Request for Sample of the report browse through https://univdatos.com/get-a-free-sample-form-php/?product_id=21049

Based on end-user, the market is bifurcated into hospitals, blood banks, diagnostic laboratories, and others. In 2020, the blood bank category accounted for the majority share in the global market. This is due to a large number of disease screening and blood typing services performed before transfusion therapy, in these facilities. Furthermore, stringent regulations related to maintaining the safety of blood supply through disease screening is further driving the market. Some of the standard tests performed in these end-use settings with the donated blood include blood typing, Rh typing, unexpected RBC antibody screening, and infectious disease screening.

For a better understanding of the market, the report provides a detailed analysis of major regions and countries including North America (U.S., Canada, Rest of America); Europe (Germany, U.K., France, Spain, Italy, Rest of Europe); Asia-Pacific (China, India, Japan, Australia, Rest of Asia-Pacific) and Rest of World. In 2020, North America accounted for the significant market share. This can be attributed to the Increasing health awareness, high disposable income, favorable reimbursement policies, and well-established healthcare infrastructure are some of the key factors boosting the regional market. According to Community Blood Center data, every day around 43,000 pints of donated blood is used in both the U.S. and Canada. According to Community Blood Center (CBC) data, every day around 43,000 pints of donated blood is used in both the U.S. and Canada.

Request for Sample of the report browse through https://univdatos.com/get-a-free-sample-form-php/?product_id=21049

Some of the major companies operating in the blood transfusion diagnostics include Immucor, Inc., Ortho Clinical Diagnostics, Abbott, Bio-Rad Laboratories, F. Hoffmann-La Roche AG, Quotient Limited, BAG Healthcare GmbH, DiaSorin S.P.A., Danaher, BIO KIT (Werfen)

Blood transfusion diagnostics Market Segmentation

Market Insight, by Product

  • Reagents & Kits, Instruments
  • Reagents & Kits        

Market Insight, by Application

  • Blood Grouping
  • Disease Screening
    • Serological Disease Screening
    • Molecular Disease Screening

Market Insight, by End-User

  • Hospitals
  • Blood Banks
  • Diagnostic Laboratories
  • Others

Market Insight, by Region

  • North America Blood Transfusion Diagnostics
    • U.S.
    • Canada
    • Rest of America
  • Europe Blood Transfusion Diagnostics
    • Germanyq
    • U.K.
    • France
    • Spain
    • Italy
    • Rest of Europe
  • Asia-Pacific Blood Transfusion Diagnostics
    • China
    • India
    • Japan
    • Australia
    • Rest of Asia-Pacific
  • Rest of the world Blood Transfusion Diagnostics

Top Company Profiles

  • Immucor Inc.
    • Ortho Clinical Diagnostics
    • Abbott
    • Bio-Rad Laboratories
    • F. Hoffmann-La Roche AG
    • Quotient Limited
    • BAG Healthcare GmbH
    • DiaSorin S.P.A.
    • Danaher
    • BIOKIT (Werfen)

Leave A Comment

Select Language